Methinks Software has announced the launch of Neuro-rescue, a project that combines artificial intelligence and telemedicine to accelerate the diagnosis and treatment of neurological conditions in non-specialized emergency departments.
The initiative is backed by €2.19 million in funding from the Agencia Estatal de Investigación (AEI), within the framework of the 2024 Public-Private Collaboration programme. The project brings together a leading consortium including Methinks AI, Fundación Vithas, Fundació Món Clínic, and Atrys, with the aim of strengthening the ability of general emergency departments to detect severe neurological conditions early and rapidly refer patients for life-saving specialized treatment.
Unlocking the potential of routine CT scans with AI
The goal of Neuro-rescue is to leverage one of the most common emergency tests—non-contrast head CT scans—to enable early detection of neurological diseases that often go unnoticed. Thanks to advanced AI algorithms developed by Methinks AI, the platform can automatically analyse these images and identify signs consistent with intracranial aneurysms, vascular occlusions, brain hemorrhages, and other treatable conditions.
This approach transforms a routine diagnostic tool into an advanced screening system, significantly reducing time to diagnosis—a critical factor in improving patient outcomes.
Methinks AI brings proven expertise in AI-based neuroimaging analysis, with CE-marked technology already deployed in clinical environments, contributing to advances in acute stroke care worldwide.
“Sabemos que muchas personas conviven con aneurismas intracraneales u otras patologías neurológicas tratables sin diagnosticar. La oportunidad está en que estas pruebas ya se realizan de forma rutinaria; si somos capaces de detectar señales sutiles en ellas, podemos escalar el diagnóstico precoz y sistemático”, explains Víctor Salvia, VP of R&D at Methinks AI.
The project goes beyond automated analysis by combining AI detection with telemedicine and clinical integration to ensure that insights translate into action. The platform enables automated identification of neurological abnormalities from non-contrast CT scans, tailored to non-specialized environments and supporting general practitioners in early detection of severe conditions.
It also provides remote support from radiologists and neurologists for image interpretation and clinical evaluation—such as NIHSS scoring—ensuring expert validation and informed decision-making even in hospitals without 24/7 neurology coverage. In addition, the tool integrates into existing care pathways, promoting structured processes and coordinated communication among healthcare professionals, ultimately reducing time to treatment.
“At Atrys, we are committed to making specialized clinical expertise available wherever patients need it, regardless of the resources of the hospital treating them,” says Facundo Nahuel, Head of Artificial Intelligence in Atrys’ teleradiology department. “By combining artificial intelligence with telemedicine, we can optimize hospital resources, support non-specialized emergency teams, and enable early detection of treatable neurological conditions—even before symptoms are clinically evident. Initiatives like Neuro-rescue expand access to advanced neurological diagnosis and help ensure that more patients receive expert evaluation at the right time.”
The Vithas group has already begun deploying this solution in 4 of its 22 hospitals. “As a hospital group, our commitment is to ensure consistent standards of quality and safety. Incorporating tools that help identify conditions that could otherwise go unnoticed in emergency tests contributes to improved detection and reduced clinical variability,” says David Baulenas, Corporate Director of Care, Quality and Innovation at Vithas and Vice President of Fundación Vithas.
Final project results are expected in the second half of 2028, following validation in real-world clinical settings.
Early detection as a priority
One of the major challenges in neurology remains the early detection of conditions such as intracranial aneurysms, which in many cases are not identified until a serious complication occurs.
“In many patients with brain aneurysms, diagnosis comes too late,” explains Xabier Urra, Head of Neurology at Hospital Clínic de Barcelona. “Non-contrast CT is the most common imaging test in emergency departments, and this is precisely where Neuro-rescue comes in: flagging suspicious findings and accelerating the diagnostic process. Detecting an aneurysm early opens the door to preventive and personalized management, rather than facing a potentially devastating subarachnoid hemorrhage.”
By extending advanced assessment capabilities beyond specialized centres, Neuro-rescue is expected to deliver significant system-wide benefits: improving access to high-quality neurological diagnosis regardless of hospital resources or location, enhancing patient outcomes and quality of life through faster detection and treatment, and increasing healthcare system efficiency through the use of remote expertise and reduced dependence on on-site specialists.
The initiative will be validated in real clinical environments through the participation of Fundación Vithas and Fundació Món Clínic, and integrated into Atrys’ telemedicine infrastructure. Neuro-rescue represents a significant step toward more accessible, scalable, and proactive neurological care.
About Methinks AI
Founded in 2016, Methinks AI is a venture-backed, commercial-stage digital health company specializing in AI-based imaging assessment solutions for neurovascular emergencies. Its mission is to enable universal and timely access to healthcare through advanced and accessible technology.
Methinks AI is the first company to obtain CE marking for an AI-based large vessel occlusion (LVO) assessment support solution using non-contrast CT scans, contributing to advancements in early stroke care worldwide.
About Fundación Vithas
Fundación Vithas was established in Valencia on November 26, 2003, and serves as the research, training, and social action arm of the Vithas Group. The Foundation promotes and supports the research activities of medical professionals, acting as both a framework for developing research projects within Vithas hospitals and as an advisory, management, and coordination body.
In 2025, Fundación Vithas managed 128 active clinical trials involving 963 patients and conducted 26 observational studies with a total of 340 patients. In addition to its research activity, the Foundation is actively involved in educational and social initiatives.
About Fundació Món Clínic
Founded in 2021, Fundació Món Clínic is a non-profit organization closely linked to Hospital Clínic de Barcelona, one of Spain’s leading university hospitals with national and international recognition.
Its mission is to protect health and promote well-being by advancing healthcare delivery, biomedical research and innovation, professional training, and social initiatives.
Through the Barcelona Clinical Coordinating Center (BCCC), the Foundation operates as a full-service contract research organization (CRO), offering clinical trial design, monitoring, and analysis services, as well as a specialized Image Core Lab for centralized imaging analysis.
About Atrys
Atrys is a healthcare company operating in six countries, providing clinical services in teleradiology, oncology, pathology, and nuclear medicine. It delivers solutions aimed at improving patient care and addressing long-term structural challenges in healthcare systems
cloud technology axon
SEG is an independent manufacturer of medium-voltage protection relays...
